Skip to content

CELSITE 5430425Recalls & reported problems

B Braun Interventional Systems, Inc · CELSITE ST301 ST SET SIL 8,5F IV USA · Class 2 · Implant

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 04046963594817), received between Jul 4, 2016 and Dec 22, 2016 — classified as 3 injuries.

The most frequently reported specific device problem is “Detachment Of Device Component” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Detachment Of Device Component1
  • Leak/Splash1
  • Material Separation1

Patient problems

  • Foreign Body In Patient2
  • No Information1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 22, 2016Material Separation; Material Separation

    PATIENT'S FAMILY CONTACTED B. BRAUN INTERVENTIONAL SYSTEMS TO REPORT THE FRAGMENT OF A PORT CATHETER SEVERING AND MIGRATING TO RIGHT ATRIUM, WHICH WAS SUCCESSFULLY RETRIEVED. PATIENT HAD PORT DUE TO DIAGNOSIS OF CANCER. SHORTLY AFTER DISCHARGE PATIENT FELT LIKE SOMETHING MOVED IN HER CHEST AND BEGAN EXPERIENCING CHEST PAINS. PATIENT RETURNED TO IMPLANTING HOSPITAL AND WAS TOLD THAT PAINS WERE ASSOCIATED WITH PORT "SETTLING IN" AND WAS SENT HOME. CHEST PAINS PERSISTED, PATIENT WENT TO SECOND HOSPITAL WHERE THEY PERFORMED CHEST X-RAY AND DETERMINED A PIECE OF THE PORT CATHETER BROKE OFF AND WENT INTO HEART. CATHETER SEGMENT WAS RETRIEVED PERCUTANEOUSLY THROUGH JUGULAR VEIN.

    Patient problems: Foreign Body In Patient

    MAUDE report 6197787 ↗
  • InjuryOct 5, 2016Detachment Of Device Component; Detachment Of Device Component

    ON (B)(6) 2016: IMPLANTATION OF AN ACCESS PORT VIA THE RIGHT SUBCLAVIAN VEIN. THE CORRECT CATHETER CONNECTION WAS CONFIRMED. ON (B)(6) 2016: DURING THE SECOND CHEMOTHERAPY ADMINISTRATION, DISCONNECTION FO THE CATHETER IS NOTED. THE CATHETER WAS REMOVED BY FEMORAL APPROACH DUE TO ITS MIGRATION IN THE VENA CAVA. ON (B)(6) 2016: EXPLANTATION OF THE ACCESS PORT AND PLACEMENT OF A SECOND ONE. REMARK: NO PROBLEM DURING THE ADMINISTRATION OF THE FIRST CHEMOTHERAPY TREATMENT.

    Patient problems: Foreign Body In Patient

    MAUDE report 5999949 ↗
  • InjuryJul 4, 2016Leak/Splash; Leak/Splash

    LEAKAGE OF CHEMOTHERAPY DRUG AROUND THE ACCESS PORT. SURGERY IN EMERGENCY TO REMOVE THE ACCESS PORT SYSTEM.

    Patient problems: No Information

    MAUDE report 5767951 ↗

Other PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices

All PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.